# Change in Brain Metabolism and Cognitive Function by Aripiprazole

> **NCT01562808** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 15 (actual)

## Conditions studied

- Antipsychotics
- Cognition
- Brain Metabolism
- Dopamine Receptor Occupancy

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT01562808
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-05
- **Final completion:** 2012-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562808, "Change in Brain Metabolism and Cognitive Function by Aripiprazole". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01562808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*